HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: hrt.2007.136044v1 94/5/549    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Google Scholar Articles by Bakhai, A. PubMed PubMed Citation Articles by Bakhai, A. Topic Collections Relevant Article

How to cost cardiovascular care

Correspondence to:
Dr A Bakhai, Barnet and Chase Farm NHS Trust, Wellhouse Lane, Barnet, EN5 3DJ, UK; ameet.bakhai@bcf.nhs.uk

The first 150 words of the full text of this article appear below.

Health economics is gaining increasing importance in cardiovascular disease management. This is not surprising given the growing numbers of treatments, devices and diagnostic tools available each year in an everlasting quest to prevent the further occurrence of cardiovascular events. The question that arrives inevitably then is—which treatments are worth their value?¹ Owing to the increasing use of intracardiac defibrillators, cardiac resynchronisation, percutaneous valve implantations; the impending wave of stem cell-based technologies from myocyte replacement to cardiac autotransplantation; and the ever increasing array of diagnostic techniques from four-dimensional echocardiography to computed tomography angiography, cardiac magnetic resonance imaging and implantable reveal devices, the money spent on cardiovascular disease continues to escalate and therefore clinicians need to appreciate and generate cost-effectiveness data with which to inform clinical choices.

A search of PubMed,² using the terms cost effectiveness or health economics and combining these with any of the terms cardiac, heart, cardiovascular or coronary, . . . [Full text of this article]

Relevant Article

Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis

L Liao, D F Kong, Z Samad, P A Pappas, J G Jollis, S S Lin, A Wang, V G Fowler, Jr, V H Chu, D J Sexton, G R Corey, and C H Cabell
Heart 2008 94: e18. [Abstract] [Full Text] [PDF]